How to use the speech recognition tool?
NCT04525261
RPE65-NHS
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
Type: Observational
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2020-05-01
- Closing Date: 0000-00-00
Criteria
Inclusion: subjects diagnosed with retinitis pigmentosa or Leber congenital amaurosis
Exclusion: participation in a clinical study with an investigational drug during the retrospective study time period (i.e., from 01/01/1990 to study start date)
Children: Yes
Adults: Yes
Funder Type: other
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)